Expanding the Possibilities of Wound Care: Antimicrobial Hydrogel

Puracyn Plus Professional Formula Antimicrobial Hydrogel is designed to add and maintain moisture in the wound bed. A moist wound and skin environment facilitates autolytic debridement and is beneficial to wound management and the wound healing process. Puracyn Plus Professional Formula Antimicrobial Hydrogel is an FDA-cleared 510(k) product for use by healthcare professionals to treat the following types of wounds:

• Acute and dermal wounds
• Partial and full-thickness wounds
• First and second-degree burns
• Diabetic ulcers and stasis ulcers
• Stage I-IV pressure injuries
• Surgical wounds (incisions, donor and graft sites)
• Abrasions and minor skin irritations
• Trauma wounds
• Various dermatoses including atopic dermatitis

Applications and Benefits

Puracyn Plus Professional Formula Antimicrobial Hydrogel has many benefits:

• Non-toxic and non-irritating
• Contains no steroids or antibiotics
• Contains no alcohol or iodine
• Requires no mixing or diluting
• Supports reduction of wound odor
• Adds moisture to dry wound beds
• Moistens and lubricates absorbent wound dressings
• Relieves itching and pain associated with dermal irritations
• Environmentally friendly—no special disposal required

REIMBURSEMENT FOR PURACYN^® PLUS PROFESSIONAL FORMULA ANTIMICROBIAL HYDROGEL

Hydrogel Billing Information

• Hydrogel dressings are covered when used on full-thickness wounds with minimal or no exudate (e.g. Stage III or IV injuries).
• Hydrogel dressings are not usually medically necessary for Stage II injuries.
• Documentation must substantiate the medical necessity for use of hydrogel dressings for Stage II injuries (e.g. location of injury is in the sacrococcygeal area).
• Usual dressing change for hydrogel wound covers without adhesive border or hydrogel wound fillers is up to once per day.
• The quantity of hydrogel filler used for each wound must not exceed the amount needed to line the surface of the wound. Additional amounts used to fill a cavity are not medically necessary.
• Documentation must substantiate the medical necessity for code A6248 billed in excess of 3 units (fluid ounces) per wound in 30 days.
• Use of more than one type of hydrogel dressing (filler, cover, or impregnated gauze) on the same wound at the same time is not medically necessary.

DISCLAIMER: This information does not guarantee reimbursement, but provides guidance for accurate documentation and appropriate usage for hydrogel wound filler. Should you need further assistance or have specific coding questions, please contact your regional DMERC or intermediary. It is the manufacturer’s intent to share this information with healthcare professionals to highlight awareness of the reimbursement process.

ABOUT INNOVACYN, INC.

Innovacyn, Inc. is dedicated to improving wound management outcomes across the world. Family-owned and operated, everything we do is inspired by this vision. From hand-building our facilities and growing a dedicated team, to delivering the highest-quality products, every step of our process is made with the power of change in mind.

Since 2009, Innovacyn, Inc. has been a leader in creating innovative medical devices and solutions, and driving advancements in the human and animal health industries. Innovacyn, Inc. manufactures and markets the Puracyn^® Plus Family of Products for human use, and the Vetericyn^® Family of Products for animal use. Innovacyn, Inc. is headquartered in Rialto, CA, USA where the company develops and manufactures its line of innovative hypochlorous products.

The Gold Standard in Hypochlorous Technology

Innovacyn, Inc. is a trusted family dedicated to providing the most advanced hypochlorous products on the wound care market.

• Innovacyn, Inc. promotes products we believe will revolutionize healthcare, create value for our trade partners, and enrich the lives of consumers. Our goal is to change wound management paradigms and create solutions for a better tomorrow.
• Innovacyn, Inc. produces innovative healthcare products based on advanced scientific research.
• Innovacyn, Inc. is committed to providing clinicians and patients with products to support and advance the awareness and science of wound care.

Our Process

• From research and development to manufacturing, Innovacyn, Inc. produces all Puracyn products 100% in-house. Our commitment to quality and teamwork ensures a standard of excellence through every stage of production.
• Our FDA-registered manufacturing facilities are state of the art.

A Commitment to Wound Care

Innovacyn, Inc. is committed to providing clinicians and patients with the products and support to advance the awareness and science of wound care. We fund ongoing research and wound care education programs to help progress knowledge and innovation within the field. We proudly support non-profits such as Wound Reach Foundation and Wounded Warriors in local communities, and Wound Relief in Haiti.

High Quality & Compliance

Innovacyn, Inc. is committed to providing high quality medical devices that focus on wound care management. This commitment is accomplished through:

• Compliance to the FDA QSR, ISO 9001, ISO 13485, CAN/CSA-ISO 13485:03, CMDR SOR/98-282, and Council Directive 93/42/EEC of 14 June 1993, concerning medical devices (MDD), as amended by 2007/47/EC.
• Communicating company goals and quality objectives throughout the organization.
• Continual review and improvement of the Quality Management System to ensure the highest quality of all products and customer satisfaction.